Clinical Trial Update: Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of esomeprazole 20 mg delayed-release capsules in healthy adults completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Diseases

Drugs mentioned

• Esomeprazole 20 mg delayed-release capsules (esomeprazole)

Snippet

Sponsor: HALEON | Conditions: Gastrointestinal Diseases | Phase 1 | Status: COMPLETED | Results posted: 2024-02-05